GOLDMAN SACHS GROUP INC - ZS PHARMA INC ownership

ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 128 filers reported holding ZS PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ZS PHARMA INC
ValueSharesWeighting
Q3 2015$8,229,000
+1148.7%
125,332
+896.7%
0.00%
Q2 2015$659,00012,5750.00%
Other shareholders
ZS PHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Devon Park Associates, LLC 2,576,723$169,188,00084.73%
DAFNA Capital Management LLC 66,194$4,346,0004.31%
Opaleye Management Inc. 95,000$6,238,0003.07%
Redmile Group, LLC 514,107$33,756,0002.56%
SCOPIA CAPITAL MANAGEMENT LP 1,002,444$65,820,0001.41%
MAZAMA CAPITAL MANAGEMENT INC 76,779$5,041,0001.05%
Kerrisdale Advisers, LLC 45,021$2,956,0000.86%
Rock Springs Capital Management LP 155,000$10,177,0000.83%
USS Investment Management Ltd 590,396$38,765,0000.69%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 21,479$1,410,0000.67%
View complete list of ZS PHARMA INC shareholders